Despite the fact that acute TNF-α blockade might present a short-term beneficial effect on anti-PD-1-related CVAEs, long-term TNF-α inhibition is implicated with CD8 + -T-cell senescence and toxicity which might lead to a possible cancer relapse [9]. Here, CD8A is linked to cancer.